Results 11 to 20 of about 4,572,461 (301)
Aspect of Thrombolytic Therapy: A Review
The Scientific World Journal, 2014 Thrombolytic therapy, also known as clot busting drug, is a breakthrough treatment which has saved untold lives. It has been used in the clinical area to treat venous and arterial thromboembolic complaints which are a foremost cause of death.
Md. Ramjan Ali +6 more
semanticscholar +2 more sources
Repeated Thrombolytic Therapy in Patients with Recurrent Acute Ischemic Stroke [PDF]
Journal of Stroke, 2013 Background and Purpose Widespread use of thrombolytic treatments, along with improved chances of survival after an initial ischemic stroke, increases the possibility of repeated thrombolysis.
H. S. Yoo +9 more
semanticscholar +2 more sources
RESCUING THE ISCHEMIC PENUMBRA—OUR EXPIRIENCE [PDF]
Sanamed, 2013 Objectives: Over one million strokes per year are occurring in Europe. Brain stroke is one of the most important death and disability causes in Europe and USA.
Ivkovic Aleksandar, Milosavljevic Tamara
core +2 more sources
Knowledge of thrombolytic therapy for acute ischemic stroke among community residents in western urban China. [PDF]
PLoS ONE, 2014 Thrombolytic therapy rate for acute ischemic stroke remains low, and improving public awareness of thrombolytic therapy may be helpful to reduce delay and increase chances of thrombolytic therapy.
Juan Yang +7 more
doaj +1 more source
Thrombolytic Therapy for Massive Pulmonary Embolism in an Antiphospholipid Syndrome Patient With Severe Thrombocytopenia: A Case Report. [PDF]
Clin Case RepABSTRACT Thrombocytopenia (TCP) is a well‐known contraindication for thrombolytic therapy due to the associated risk of bleeding. This report discusses a 34‐year‐old woman presented with massive pulmonary embolism (PE) and severe TCP. She was treated with systemic thrombolysis (ST), and fortunately, a good therapeutic response was achieved without ...
Ahmadzadeh A +5 more
europepmc +2 more sources
Sakarya Tıp Dergisi, 2021 Objective: Neutrophil to lymphocyte (NLR) and platelet to lymphocyte (PLR) ratios play an important role in monitoring the progression of the disease and determining the course of the disease in patients with acute pulmonary thromboembolism (APTE).
Ayhan Coşgun, Hüseyin Ören
doaj +1 more source
Евразийский Кардиологический Журнал, 2023 Presented clinical case report illustrates nonstandart approach use repeat thrombolytic therapy patient 49 y.o. with acute circular – apical myocardial infarction, after noneffective primary systemic thrombolytic therapy rtPA.
D. V. Bosikov +3 more
doaj +1 more source
Application and risk prediction of thrombolytic therapy in cardio-cerebrovascular diseases: a review. [PDF]
Thromb J, 2023 Cardiocerebrovascular diseases (CVDs) are the leading cause of death worldwide, consuming huge healthcare budget. For CVD patients, the prompt assessment and appropriate administration is the crux to save life and improve prognosis. Thrombolytic therapy,
Zhang K, Jiang Y, Zeng H, Zhu H.
europepmc +2 more sources
Tratamento trombolítico do enfarte agudo do miocárdio. Primeira de três partes.
Acta Médica Portuguesa, 1998 I-Rationale of thrombolytic therapy in acute myocardial infarction (AMI). II-Thrombolytic drugs. III-Effects of thrombolytic therapy on mortality. IV-Studies comparing the effects of various thrombolytic agents on mortality.
J T Soares-Costa +2 more
doaj +1 more source
Research in Cardiovascular Medicine, 2016 Background: Thrombolytic therapy in patients with sub-massive pulmonaryembolism (SMPTE) needs further assessment. Objectives: The current study aimed to assess a potential benefit of thrombolytic and non-thrombolytic therapy in patients with SMPTE ...
Hasan Allah Sadeghi +4 more
doaj +1 more source